3 unknown, 1 recruiting. 3 Early Phase 1, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 3 | Unknown 2, Recruiting 1 |
| Not applicable | 1 | Unknown 1 |
Follow JIANG LONGWEI: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety Study of DC-CIK Cell Therapy Combined With Epaloliposide, Vortexil, and Regorafenib as Third-line Treatment for Advanced Colorectal Cancer. DC-CIK combined with regorafenib ,Iparomlimab and Tuvonralimab Injection - DC-CIK Treatment, Regorafenib | Early Phase 1 | Recruiting | JIANG LONGWEI | 14 | 2025-11-19 | 2026-01-15 |
| A Single-arm, Open, Exploratory Clinical Study of Allogeneic CAR-T Cells in the Treatment of Relapsed/Refractory Brain Gliomas With Positive CD70 Expression CAR-T - Gliomas | Early Phase 1 | Unknown | JIANG LONGWEI | 3 | 2024-06-13 | 2025-02-14 |
| A Clinical Study of Albumin-bound Paclitaxel/Granulocyte-based Therapy for Recurrent/Metastatic Breast Cancer Albumin paclitaxel/neutrophil drug - Breast Cancer | Not applicable | Unknown | JIANG LONGWEI | 1 | 2024-06-01 | 2025-02-12 |
| A Study of Tumor Neoantigen-specific T Cells in the Treatment of Advanced Solid Tumors tumor neoantigen specific T cell - Tumor, Solid | Early Phase 1 | Unknown | JIANG LONGWEI | 6 | 2024-04-18 | 2024-05-28 |
Breast Neoplasms (1) · Colorectal Neoplasms (1) · Glioma (1) · Neoplasms (1)
regorafenib (1)
China (4)
Jia Shaochang, MD (2) · Jia Shaochang, doctor (1) · Lei Zengjie (1)